Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-040889
Filing Date
2021-12-08
Accepted
2021-12-08 18:53:28
Documents
2
Period of Report
2021-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1437
2 EXHIBIT 24 brhc10031675_ex24.htm EX-24 6379
  Complete submission text file 0001140361-21-040889.txt   9284
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TELIGENT, INC. 105 LINCOLN AVENUE BUENA NJ 08310
Business Address
Wilson Martin (Reporting) CIK: 0001704342 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36829 | Film No.: 211479871